MPMina Peric

Mina Peric

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mina Peric has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic Transcriptional Regulatory Programs Reveal Pharmacologically Targetable Vulnerabilities in Treatment-Naive Osteosarcoma

    by Luka Bojic, Mina Peric, Isidora Petrovic, Milena Milivojevic

    Osteosarcoma is an aggressive malignancy whose treatment has changed little over the past decades, and outcomes remain poor. Although transcriptomic studies have provided insights into osteosarcoma biology, many include metastatic or post-treatment tumours, potentially obscuring transcriptional programs associated with intrinsic tumour aggressiveness. To address this limitation, we analysed transcriptomic profiles exclusively from treatment-naive, non-metastatic osteosarcoma patients to reconstruct prognostic transcriptional regulons associated with outcome. We identified distinct transcriptional programs associated with favourable and unfavourable outcomes. Tumours linked to poor prognosis were characterized by coordinated proliferative and metabolic transcriptional programs controlled by three regulatory hubs: CTCF, E2F4, and SP1, whose regulon enrichments showed strong associations with patient survival. To explore whether these regulatory networks could be pharmacologically modulated, molecular docking and dynamics simulations were performed, revealing potentially stable interactions between the hesperidin and the DNA-binding domains of these key transcription factors. Transcriptomic analysis of osteosarcoma cells treated with hesperidin revealed alterations in the identified regulons’ composition and decreased transcription factor activity. Together, these findings identify a transcriptional regulatory architecture underlying aggressive osteosarcoma, revealing novel prognostic biomarkers and suggesting that pharmacological modulation of master regulators such as CTCF, E2F4, and SP1, may represent a strategy to target transcriptional vulnerabilities in this malignancy.

  • Evaluation of biological properties of the light-cured, CAD/CAM milled, and 3D printed dental composites after artificial aging – an in vitro study

    by Nikola Živković, Stefan Vulović, Miloš Lazarević, Ljiljana Đukić, Aleksandar Jakovljević, Ivana Dinić, Mina Perić, Aleksandra Milić Lemić


  • Open Access

    Exploring the Biological and Chemical Properties of Emerging 3D-Printed Dental Resin Composites Compared to Conventional Light-Cured Materials

    by Nikola Živković, Stefan Vulović, Miloš Lazarević, Anja Baraba, Aleksandar Jakovljević, Mina Perić, Jelena Mitrić, Aleksandra Milić Lemić

    Advances in additive manufacturing have accelerated the development of 3D-printed dental resin composites. These materials contain a higher proportion of organic matrix and less filler than light-cured representatives, which may affect their behavior in the oral environment. This study aimed to evaluate the biological and chemical properties of 3D-printed dental resin composites before and after artificial aging, and to compare them with the light-cured representative. Specimens from a light-cured composite (Omnichroma—OMCR) and two 3D-printed composites (GT Temp PRINT—GTPR; SprintRay CROWN—SPRY) were subjected to aging treatments: unaged (T0) or thermocycled for 5000 (T1) and 10,000 cycles (T2). Biological evaluation was performed using MTT assay and Live/Dead cell fluorescence microscopy using human gingival fibroblasts, whereas Raman spectroscopy analysed materials’ structural changes. Materials exhibited good biocompatibility (>70% cell viability), with OMCR displaying greater variability. OMCR was more susceptible to chemical degradation under thermal stresses than both 3D-printed materials. Tested 3D-printed composites can provide comparable or even superior biological and chemical properties compared to light-cured representative, likely due to optimized resin formulations and post-curing protocols that improve polymer network organization and reduce residual monomer release. These findings support the potential of tested 3D-printed composites for manufacturing dental restorations.


  • Open Access

    Exploratory Analysis of Molecular Subtypes in Early-Stage Osteosarcoma: Identifying Resistance and Optimizing Therapy

    by Luka Bojic, Mina Peric, Jelena Karanovic, Emilija Milosevic, Natasa Kovacevic Grujicic, Milena Milivojevic

    Background: Osteosarcoma (OS) is a highly aggressive bone malignancy with limited treatment options and poor prognosis. This exploratory study aimed to identify molecular subtypes of early-stage, treatment-naive OS to guide precise therapeutic strategies. Methods: We analyzed RNA-seq data obtained from tumor tissues from 102 OS patients using a non-negative matrix factorization algorithm (NMF) to classify the tumors into three subtypes: S1, S2, and S3. Differential gene expression was evaluated using DESeq2, followed by functional enrichment analysis with clusterProfiler and CancerHallmarks. The tumor microenvironment was assessed through ESTIMATE and CIBERSORT, and drug sensitivity was predicted using OncoPredict. SAOS-2 and MG63 cells, representing the S1 subtype, were used in the viability essays to determine the effect of hesperidin, a natural phenolic compound noted for its anti-cancer potential, alone and in combination with doxorubicin and 5-fluorouracil. Results: This study revealed three OS subtypes: S1 was enriched in cell cycle regulation, vesicular transport, and RNA metabolism while S2 and S3 were enriched in pathways related to extracellular matrix organization and protein translation, respectively. S1 displayed high tumor purity, significant chemoresistance, and overexpression of KIF20 A, correlating with poor prognosis. AURKB, a hesperidin target, was implicated in S1 pathogenesis. In vitro, hesperidin significantly reduced the viability of SAOS-2 and MG63 cells and enhanced doxorubicin efficacy. Conclusions: Our findings support the molecular subclassification of OS, emphasizing subtype-specific mechanisms of tumor progression and chemoresistance, with hesperidin offering potential as a therapeutic adjunct for high-risk OS patients.


  • Open Access

    Molecular Subtyping of Early-Stage Osteosarcoma: Identifying Resistance and Optimizing Therapy

    by Luka Bojic, Mina Peric, Jelena Karanovic, Emilija Milosevic, Natasa Kovacevic Grujicic, Milena Milivojevic

    Background: Osteosarcoma (OS) is a highly aggressive primary bone malignancy, for which treatment and prognosis remain unchanged for three decades. This study aimed to delineate molecular subtypes of early-stage, treatment-naive OS to improve molecular stratification and guide precise therapeutic strategies. Methods: The top 10% of the most variable genes of 102 OS tumour tissues were used in NMF to classify the tumours into three subtypes, S1, S2, and S3. Differential expression analysis was carried out using DESeq2 and functional enrichment analysis using clusterProfiler and CancerHallmarks. Tumor microenvironment composition was estimated through ESTIMATE and CIBERSORT, and drug sensitivity prediction using OncoPredict. NMF was also applied to RNA-seq data from 19 osteosarcoma cell lines and DEGs between the groups were correlated with the DEGs from patients' subtypes. SAOS-2, representing S1, was used in the viability assays to determine the effects of hesperidin, alone or in combination with doxorubicin and 5-fluorouracil. Results: S1 was enriched in cell cycle regulation, vesicular transport, and RNA metabolism with high tumor purity and high resistance to chemotherapeutics. S2 and S3 were enriched in extracellular matrix organization and protein translation pathways, respectively. KIF20A was significantly overexpressed gene indicating a poor prognosis of S1. AURKB, a hesperidin target, was found as an important gene for the pathogenesis of S1. Hesperidin significantly reduced SAOS-2 cell viability and enhanced the efficacy of doxorubicin. Conclusions: Our results offer a strong molecular basis for OS subclassification, highlighting subtype-specific mechanisms of tumour progression and chemoresistance. Our findings support the prospect of customized therapeutic approaches, with hesperidin being a promising co-adjuvant to improve the prognosis of high-risk OS patients.


  • Open Access

    The Role of SOX2 and SOX9 Transcription Factors in the Reactivation-Related Functional Properties of NT2/D1-Derived Astrocytes

    by Vanda Balint, Mina Peric, Sanja Dacic, Danijela Stanisavljevic Ninkovic, Jelena Marjanovic, Jelena Popovic, Milena Stevanovic, Andrijana Lazic

    Astrocytes are the main homeostatic cells in the central nervous system, with the unique ability to transform from quiescent into a reactive state in response to pathological conditions by reacquiring some precursor properties. This process is known as reactive astrogliosis, a compensatory response that mediates tissue damage and recovery. Although it is well known that SOX transcription factors drive the expression of phenotype-specific genetic programs during neurodevelopment, their roles in mature astrocytes have not been studied extensively. We focused on the transcription factors SOX2 and SOX9, shown to be re-expressed in reactive astrocytes, in order to study the reactivation-related functional properties of astrocytes mediated by those proteins. We performed an initial screening of SOX2 and SOX9 expression after sensorimotor cortex ablation injury in rats and conducted gain-of-function studies in vitro using astrocytes derived from the human NT2/D1 cell line. Our results revealed the direct involvement of SOX2 in the reacquisition of proliferation in mature NT2/D1-derived astrocytes, while SOX9 overexpression increased migratory potential and glutamate uptake in these cells. Our results imply that modulation of SOX gene expression may change the functional properties of astrocytes, which holds promise for the discovery of potential therapeutic targets in the development of novel strategies for tissue regeneration and recovery.


  • Open Access

    The Effect of Liquid-Phase Exfoliated Graphene Film on Neurodifferentiation of Stem Cells from Apical Papilla

    by Jelena Simonovic, Bosko Toljic, Milos Lazarevic, Maja Milosevic Markovic, Mina Peric, Jasna Vujin, Radmila Panajotovic, Jelena Milasin

    Background: Dental stem cells, which originate from the neural crest, due to their easy accessibility might be good candidates in neuro-regenerative procedures, along with graphene-based nanomaterials shown to promote neurogenesis in vitro. We aimed to explore the potential of liquid-phase exfoliated graphene (LPEG) film to stimulate the neuro-differentiation of stem cells from apical papilla (SCAP). Methods: The experimental procedure was structured as follows: (1) fabrication of graphene film; (2) isolation, cultivation and SCAP stemness characterization by flowcytometry, multilineage differentiation (osteo, chondro and adipo) and quantitative PCR (qPCR); (3) SCAP neuro-induction by cultivation on polyethylene terephthalate (PET) coated with graphene film; (4) evaluation of neural differentiation by means of several microscopy techniques (light, confocal, atomic force and scanning electron microscopy), followed by neural marker gene expression analysis using qPCR. Results: SCAP demonstrated exceptional stemness, as judged by mesenchymal markers’ expression (CD73, CD90 and CD105), and by multilineage differentiation capacity (osteo, chondro and adipo-differentiation). Neuro-induction of SCAP grown on PET coated with graphene film resulted in neuron-like cellular phenotype observed under different microscopes. This was corroborated by the high gene expression of all examined key neuronal markers (Ngn2, NF-M, Nestin, MAP2, MASH1). Conclusions: The ability of SCAPs to differentiate toward neural lineages was markedly enhanced by graphene film.


  • Open Access

    Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies

    by Andrijana Lazic, Vanda Balint, Danijela Stanisavljevic Ninkovic, Mina Peric, Milena Stevanovic

    Astrocytes, as the most abundant glial cells in the central nervous system, are tightly integrated into neural networks and participate in numerous aspects of brain physiology and pathology. They are the main homeostatic cells in the central nervous system, and the loss of astrocyte physiological functions and/or gain of pro-inflammatory functions, due to their reactivation or cellular senescence, can have profound impacts on the surrounding microenvironment with pathological outcomes. Although the importance of astrocytes is generally recognized, and both senescence and reactive astrogliosis have been extensively reviewed independently, there are only a few comparative overviews of these complex processes. In this review, we summarize the latest data regarding astrocyte reactivation and senescence, and outline similarities and differences between these phenotypes from morphological, functional, and molecular points of view. A special focus has been given to neurodegenerative diseases, where these phenotypic alternations of astrocytes are significantly implicated. We also summarize current perspectives regarding new advances in model systems based on astrocytes as well as data pointing to these glial cells as potential therapeutic targets.


  • Open Access

    Vitamin B Complex and Experimental Autoimmune Encephalomyelitis –Attenuation of the Clinical Signs and Gut Microbiota Dysbiosis

    by Marija Mandić, Katarina Mitić, Predrag Nedeljković, Mina Perić, Bojan Božić, Tanja Lunić, Ana Bačić, Mirjana Rajilić-Stojanović, Sanja Peković, Biljana Božić Nedeljković

    The present study aimed to investigate the neuroprotective effects of the vitamin B complex (B1, B2, B3, B5, B6, and B12—VBC), by studying the changes in the femoral nerve, quadriceps muscle, popliteal lymph nodes and gut microbiota in the rat model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). VBC treatment attenuated clinical signs of EAE during the disease, and reduced the duration of EAE thereby contributing to a faster recovery. In VBC-treated EAE rats, a significant decrease in nerve and muscle nuclear density was revealed during the onset period of the disease, while a marked increase was detected at the end of the disease, compared with untreated EAE rats. In the lymph nodes of VBC-treated EAE rats, a fewer number of lymphoid follicles in the cortical area and smaller epithelioid granulomas were detected. The changes in microbiota composition were examined using 16S rRNA gene sequencing and bioinformatics analysis, which revealed the potential of VBC treatment in establishing and/or maintaining gut microbiota homeostasis. Finally, the present study demonstrated that VBC treatment ameliorated the cellular changes in the affected peripheral nerve, muscles innervated by this nerve, and the gut microbiota dysbiosis which occurred during the EAE.


  • Open Access

    Cysteine Peptidase Cathepsin X as a Therapeutic Target for Simultaneous TLR3/4-mediated Microglia Activation

    by Anja Pišlar, Biljana Božić Nedeljković, Mina Perić, Tanja Jakoš, Nace Zidar, Janko Kos

    Microglia are resident macrophages in the central nervous system that are involved in immune responses driven by Toll-like receptors (TLRs). Microglia-mediated inflammation can lead to central nervous system disorders, and more than one TLR might be involved in these pathological processes. The cysteine peptidase cathepsin X has been recognized as a pathogenic factor for inflammation-induced neurodegeneration. Here, we hypothesized that simultaneous TLR3 and TLR4 activation induces synergized microglia responses and that these phenotype changes affect cathepsin X expression and activity. Murine microglia BV2 cells and primary murine microglia were exposed to the TLR3 ligand polyinosinic-polycytidylic acid (poly(I:C)) and the TLR4 ligand lipopolysaccharide (LPS), individually and simultaneously. TLR3 and TLR4 co-activation resulted in increased inflammatory responses compared to individual TLR activation, where poly(I:C) and LPS induced distinct patterns of proinflammatory factors together with different patterns of cathepsin X expression and activity. TLR co-activation decreased intracellular cathepsin X activity and increased cathepsin X localization at the plasma membrane with concomitant increased extracellular cathepsin X protein levels and activity. Inhibition of cathepsin X in BV2 cells by AMS36, cathepsin X inhibitor, significantly reduced the poly(I:C)- and LPS-induced production of proinflammatory cytokines as well as apoptosis. Additionally, inhibiting the TLR3 and TLR4 common signaling pathway, PI3K, with LY294002 reduced the inflammatory responses of the poly(I:C)- and LPS-activated microglia and recovered cathepsin X activity. We here provide evidence that microglial cathepsin X strengthens microglia activation and leads to subsequent inflammation-induced neurodegeneration. As such, cathepsin X represents a therapeutic target for treating neurodegenerative diseases related to excess inflammation.